Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China.

about

Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China.

Item

http://www.wikidata.org/entity/Q49307611

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Deficient mismatch repair and ...... ective study in Eastern China.

@en

Deficient mismatch repair and ...... ective study in Eastern China.

@nl

type

Item

label

Deficient mismatch repair and ...... ective study in Eastern China.

@en

Deficient mismatch repair and ...... ective study in Eastern China.

@nl

prefLabel

Deficient mismatch repair and ...... ective study in Eastern China.

@en

Deficient mismatch repair and ...... ective study in Eastern China.

@nl

P1476

Deficient mismatch repair and ...... ective study in Eastern China.

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Huamin Liu

http://www.w3.org/2001/XMLSchema#string

Jie Wu

http://www.w3.org/2001/XMLSchema#string

Lili Wang

http://www.w3.org/2001/XMLSchema#string

Wenwen Ran

http://www.w3.org/2001/XMLSchema#string

Xiangyan Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaoming Xing

http://www.w3.org/2001/XMLSchema#string

Xiaonan Wang

http://www.w3.org/2001/XMLSchema#string

Yujing Xiao

http://www.w3.org/2001/XMLSchema#string

Yujun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Deficient mismatch repair: Read all about it (Review)

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.

Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features

Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study

P304

e4341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7717/PEERJ.4341

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423347

http://www.w3.org/2001/XMLSchema#string

P932

5804321

http://www.w3.org/2001/XMLSchema#string